Hemoglobinopathies Market
1 Introduction to Research & Analysis Reports
1.1 Hemoglobinopathies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemoglobinopathies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemoglobinopathies Overall Market Size
2.1 Global Hemoglobinopathies Market Size: 2021 VS 2028
2.2 Global Hemoglobinopathies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemoglobinopathies Players in Global Market
3.2 Top Global Hemoglobinopathies Companies Ranked by Revenue
3.3 Global Hemoglobinopathies Revenue by Companies
3.4 Top 3 and Top 5 Hemoglobinopathies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemoglobinopathies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathies Players in Global Market
3.6.1 List of Global Tier 1 Hemoglobinopathies Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hemoglobinopathies Market Size Markets, 2021 & 2028
4.1.2 Blood Transfusion
4.1.3 Iron Chelation Therapy
4.1.4 Bone Marrow Transplant
4.1.5 Others
4.2 By Type - Global Hemoglobinopathies Revenue & Forecasts
4.2.1 By Type - Global Hemoglobinopathies Revenue, 2017-2022
4.2.2 By Type - Global Hemoglobinopathies Revenue, 2023-2028
4.2.3 By Type - Global Hemoglobinopathies Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemoglobinopathies Market Size, 2021 & 2028
5.1.2 Blood Testing
5.1.3 Genetic Testing
5.1.4 Pre-Implantation Genetic Diagnosis (PGD)
5.1.5 Others
5.2 By Application - Global Hemoglobinopathies Revenue & Forecasts
5.2.1 By Application - Global Hemoglobinopathies Revenue, 2017-2022
5.2.2 By Application - Global Hemoglobinopathies Revenue, 2023-2028
5.2.3 By Application - Global Hemoglobinopathies Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hemoglobinopathies Market Size, 2021 & 2028
6.2 By Region - Global Hemoglobinopathies Revenue & Forecasts
6.2.1 By Region - Global Hemoglobinopathies Revenue, 2017-2022
6.2.2 By Region - Global Hemoglobinopathies Revenue, 2023-2028
6.2.3 By Region - Global Hemoglobinopathies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hemoglobinopathies Revenue, 2017-2028
6.3.2 US Hemoglobinopathies Market Size, 2017-2028
6.3.3 Canada Hemoglobinopathies Market Size, 2017-2028
6.3.4 Mexico Hemoglobinopathies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hemoglobinopathies Revenue, 2017-2028
6.4.2 Germany Hemoglobinopathies Market Size, 2017-2028
6.4.3 France Hemoglobinopathies Market Size, 2017-2028
6.4.4 U.K. Hemoglobinopathies Market Size, 2017-2028
6.4.5 Italy Hemoglobinopathies Market Size, 2017-2028
6.4.6 Russia Hemoglobinopathies Market Size, 2017-2028
6.4.7 Nordic Countries Hemoglobinopathies Market Size, 2017-2028
6.4.8 Benelux Hemoglobinopathies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hemoglobinopathies Revenue, 2017-2028
6.5.2 China Hemoglobinopathies Market Size, 2017-2028
6.5.3 Japan Hemoglobinopathies Market Size, 2017-2028
6.5.4 South Korea Hemoglobinopathies Market Size, 2017-2028
6.5.5 Southeast Asia Hemoglobinopathies Market Size, 2017-2028
6.5.6 India Hemoglobinopathies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hemoglobinopathies Revenue, 2017-2028
6.6.2 Brazil Hemoglobinopathies Market Size, 2017-2028
6.6.3 Argentina Hemoglobinopathies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hemoglobinopathies Revenue, 2017-2028
6.7.2 Turkey Hemoglobinopathies Market Size, 2017-2028
6.7.3 Israel Hemoglobinopathies Market Size, 2017-2028
6.7.4 Saudi Arabia Hemoglobinopathies Market Size, 2017-2028
6.7.5 UAE Hemoglobinopathies Market Size, 2017-2028
7 Players Profiles
7.1 Gamida Cell
7.1.1 Gamida Cell Corporate Summary
7.1.2 Gamida Cell Business Overview
7.1.3 Gamida Cell Hemoglobinopathies Major Product Offerings
7.1.4 Gamida Cell Hemoglobinopathies Revenue in Global Market (2017-2022)
7.1.5 Gamida Cell Key News
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Corporate Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Hemoglobinopathies Revenue in Global Market (2017-2022)
7.2.5 Alnylam Pharmaceuticals Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hemoglobinopathies Major Product Offerings
7.3.4 Sanofi Hemoglobinopathies Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Sangamo Therapeutics Inc.
7.4.1 Sangamo Therapeutics Inc. Corporate Summary
7.4.2 Sangamo Therapeutics Inc. Business Overview
7.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Major Product Offerings
7.4.4 Sangamo Therapeutics Inc. Hemoglobinopathies Revenue in Global Market (2017-2022)
7.4.5 Sangamo Therapeutics Inc. Key News
7.5 Global Blood Therapeutics
7.5.1 Global Blood Therapeutics Corporate Summary
7.5.2 Global Blood Therapeutics Business Overview
7.5.3 Global Blood Therapeutics Hemoglobinopathies Major Product Offerings
7.5.4 Global Blood Therapeutics Hemoglobinopathies Revenue in Global Market (2017-2022)
7.5.5 Global Blood Therapeutics Key News
7.6 Bluebird Bio
7.6.1 Bluebird Bio Corporate Summary
7.6.2 Bluebird Bio Business Overview
7.6.3 Bluebird Bio Hemoglobinopathies Major Product Offerings
7.6.4 Bluebird Bio Hemoglobinopathies Revenue in Global Market (2017-2022)
7.6.5 Bluebird Bio Key News
7.7 Emmaus Life Sciences Inc.
7.7.1 Emmaus Life Sciences Inc. Corporate Summary
7.7.2 Emmaus Life Sciences Inc. Business Overview
7.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Major Product Offerings
7.7.4 Emmaus Life Sciences Inc. Hemoglobinopathies Revenue in Global Market (2017-2022)
7.7.5 Emmaus Life Sciences Inc. Key News
7.8 Prolong Pharmaceuticals
7.8.1 Prolong Pharmaceuticals Corporate Summary
7.8.2 Prolong Pharmaceuticals Business Overview
7.8.3 Prolong Pharmaceuticals Hemoglobinopathies Major Product Offerings
7.8.4 Prolong Pharmaceuticals Hemoglobinopathies Revenue in Global Market (2017-2022)
7.8.5 Prolong Pharmaceuticals Key News
7.9 Celgene Corporation
7.9.1 Celgene Corporation Corporate Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Hemoglobinopathies Major Product Offerings
7.9.4 Celgene Corporation Hemoglobinopathies Revenue in Global Market (2017-2022)
7.9.5 Celgene Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hemoglobinopathies Market Opportunities & Trends in Global Market
Table 2. Hemoglobinopathies Market Drivers in Global Market
Table 3. Hemoglobinopathies Market Restraints in Global Market
Table 4. Key Players of Hemoglobinopathies in Global Market
Table 5. Top Hemoglobinopathies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemoglobinopathies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemoglobinopathies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemoglobinopathies Product Type
Table 9. List of Global Tier 1 Hemoglobinopathies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemoglobinopathies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hemoglobinopathies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemoglobinopathies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemoglobinopathies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hemoglobinopathies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemoglobinopathies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemoglobinopathies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hemoglobinopathies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemoglobinopathies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemoglobinopathies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemoglobinopathies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemoglobinopathies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemoglobinopathies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemoglobinopathies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemoglobinopathies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemoglobinopathies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemoglobinopathies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemoglobinopathies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemoglobinopathies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemoglobinopathies Revenue, (US$, Mn), 2023-2028
Table 30. Gamida Cell Corporate Summary
Table 31. Gamida Cell Hemoglobinopathies Product Offerings
Table 32. Gamida Cell Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 33. Alnylam Pharmaceuticals Corporate Summary
Table 34. Alnylam Pharmaceuticals Hemoglobinopathies Product Offerings
Table 35. Alnylam Pharmaceuticals Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Hemoglobinopathies Product Offerings
Table 38. Sanofi Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 39. Sangamo Therapeutics Inc. Corporate Summary
Table 40. Sangamo Therapeutics Inc. Hemoglobinopathies Product Offerings
Table 41. Sangamo Therapeutics Inc. Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 42. Global Blood Therapeutics Corporate Summary
Table 43. Global Blood Therapeutics Hemoglobinopathies Product Offerings
Table 44. Global Blood Therapeutics Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 45. Bluebird Bio Corporate Summary
Table 46. Bluebird Bio Hemoglobinopathies Product Offerings
Table 47. Bluebird Bio Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 48. Emmaus Life Sciences Inc. Corporate Summary
Table 49. Emmaus Life Sciences Inc. Hemoglobinopathies Product Offerings
Table 50. Emmaus Life Sciences Inc. Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 51. Prolong Pharmaceuticals Corporate Summary
Table 52. Prolong Pharmaceuticals Hemoglobinopathies Product Offerings
Table 53. Prolong Pharmaceuticals Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
Table 54. Celgene Corporation Corporate Summary
Table 55. Celgene Corporation Hemoglobinopathies Product Offerings
Table 56. Celgene Corporation Hemoglobinopathies Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hemoglobinopathies Segment by Type in 2021
Figure 2. Hemoglobinopathies Segment by Application in 2021
Figure 3. Global Hemoglobinopathies Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hemoglobinopathies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemoglobinopathies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemoglobinopathies Revenue in 2021
Figure 8. By Type - Global Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 12. US Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 16. Germany Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 24. China Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 30. Brazil Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemoglobinopathies Revenue Market Share, 2017-2028
Figure 33. Turkey Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemoglobinopathies Revenue, (US$, Mn), 2017-2028
Figure 37. Gamida Cell Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alnylam Pharmaceuticals Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sangamo Therapeutics Inc. Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Global Blood Therapeutics Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bluebird Bio Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Emmaus Life Sciences Inc. Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Prolong Pharmaceuticals Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Celgene Corporation Hemoglobinopathies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
